CNTB
Connect Biopharma Holdings Ltd
Connect Biopharma Holdings Ltd (CNTB) has 6 SEC Form 4 filings (6 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jul 1, 2026.
Insiders have net bought $4.4M over the trailing 6 months. The largest single insider purchase in this window was $4.0M by Director Huang James on Mar 31, 2026.
- Industry:Biotechnology
- CEO:Barry D. Quart
- Employees:64
- HQ:San Diego, CA, US
- IPO:2021-03-19
Insider Buying
$4.4M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$138.8M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Director | Purchase | 150,000 | $372K | Jun 2 | SEC ↗ | |
Huang JamesFirst filing | Director | Purchase | 1,160,000 | $4.0M | Apr 1 | SEC ↗ |
Related companies
Connect Biopharma Holdings Ltd is in the Healthcare sector.